Works matching IS 1021335X AND DT 2022 AND VI 47 AND IP 5

Results: 21

RETRACTION: Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8297
By:
- JIA LIU;
- BING‑FEI DONG;
- PEI‑SONG WANG;
- PEI‑YOU REN;
- SHUAI XUE;
- XIAO‑ΝAN ZHANG;
- ZHE HAN;
- GUANG CHEN
Publication type:
Article
Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8316
By:
- AI-NI TSAO;
- YU-SYUAN CHUANG;
- YEN-CHUN LIN;
- YEU SU;
- TA-CHUNG CHAO
Publication type:
Article
Blue light irradiation inhibits the growth of colon cancer and activation of cancer-associated fibroblasts.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8315
By:
- TOSHIAKI YOSHIMOTO;
- MITSUO SHIMADA;
- TAKUYA TOKUNAGA;
- TOSHIHIRO NAKAO;
- MASAAKI NISHI;
- CHIE TAKASU;
- HIDEYA KASHIHARA;
- YUMA WADA;
- SHOHEI OKIKAWA;
- KOZO YOSHIKAWA
Publication type:
Article
CORRIGENDUM.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8314
Publication type:
Article
Tumor microenvironment manipulates chemoresistance in ovarian cancer (Review).
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8313
By:
- QIAOLING ZHANG;
- JIASHAN DING;
- YINGMEI WANG;
- LINSHENG HE;
- FENGXIA XUE
Publication type:
Article
Research progress of anti-glioma chemotherapeutic drugs (Review).
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8312
By:
- YI-SHU ZHOU;
- WEI WANG;
- NA CHEN;
- LI-CUI WANG;
- JIN-BAI HUANG
Publication type:
Article
CORRIGENDUM.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8311
Publication type:
Article
TP53 loss-of-function mutations reduce sensitivity of acute leukaemia to the curaxin CBL0137.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8310
By:
- FORGIONE, MICHELLE O.;
- McCLURE, BARBARA J.;
- PAGE, ELYSE C.;
- YEUNG, DAVID T.;
- EADIE, LAURA N.;
- WHITE, DEBORAH L.
Publication type:
Article
CORRIGENDUM.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8309
Publication type:
Article
IFNγ enhances ferroptosis by increasing JAK-STAT pathway activation to suppress SLCA711 expression in adrenocortical carcinoma.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8308
By:
- XINBO YU;
- DANDAN ZHU;
- BIXIAN LUO;
- WEI KOU;
- YULING CHENG;
- YU ZHU
Publication type:
Article
Regulatory functions of miR-200b-3p in tumor development (Review).
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8307
By:
- SHENG CHEN;
- YIFENG TU;
- HANG YUAN;
- ZHAN SHI;
- YANG GUO;
- WENJING GONG;
- SHILIANG TU
Publication type:
Article
RETRACTION.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8306
Publication type:
Article
Epithelial cell adhesion molecule-targeting designed ankyrin repeat protein-toxin fusion Ec1-LoPE exhibits potent cytotoxic action in prostate cancer cells.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8305
By:
- TIANQI XU;
- YONGSHENG LIU;
- SCHULGA, ALEXEY;
- KONOVALOVA, ELENA;
- DEYEV, SERGEY M.;
- TOLMACHEV, VLADIMIR;
- VOROBYEVA, ANZHELIKA
Publication type:
Article
Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review).
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8304
By:
- HIDEYA ONISHI;
- KATSUYA NAKAMURA;
- KOSUKE YANAI;
- SHUNTARO NAGAI;
- KAZUNORI NAKAYAMA;
- YASUHIRO OYAMA;
- AKIKO FUJIMURA;
- KEIGO OZONO;
- AKIO YAMASAKI
Publication type:
Article
Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8298
By:
- NAMI SATO;
- NOZOMU SAKAI;
- KATSUNORI FURUKAWA;
- TSUKASA TAKAYASHIKI;
- SATOSHI KUBOKI;
- SHIGETSUGU TAKANO;
- GAKU OHIRA;
- HISAHIRO MATSUBARA;
- MASAYUKI OHTSUKA
Publication type:
Article
SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8302
By:
- WEN-KAI SHI;
- QIAO-LI SHANG;
- YONG-FU ZHAO
Publication type:
Article
CORRIGENDUM.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8301
Publication type:
Article
Levels of circulating mast cell progenitors and tumour-infiltrating mast cells in patients with colorectal cancer.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8300
By:
- PINGWEI ZHAO;
- PEIWEN ZHOU;
- TONGYU TANG;
- RUI SI;
- YIDING JI;
- XINTONG HU;
- ANG LI;
- YANFANG JIANG
Publication type:
Article
Tetraspanin CD9: A friend or foe of head and neck cancer (Review).
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8299
By:
- P. C., SUHASINI;
- SHETTY, SHILPA S.;
- NALILU, SUCHETHA KUMARI;
- SHETTY, PRAVEEN KUMAR;
- PATIL, PRAKASH
Publication type:
Article
miRNA-218 targets multiple oncogenes and is a therapeutic target for osteosarcoma.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8303
By:
- KENTARO SATO;
- EIJI OSAKA;
- KYOKO FUJIWARA;
- RYOTA FUJII;
- TADATERU TAKAYAMA;
- YASUAKI TOKUHASHI;
- KAZUYOSHI NAKANISHI
Publication type:
Article
RETRACTION.
Published in:
Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8297
Publication type:
Article